Literature DB >> 8282967

Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case report and review of the literature.

S Cannavò1, L Curtò, R Fazio, S Paterniti, A Blandino, T Marafioti, F Trimarchi.   

Abstract

The simultaneous occurrence of a pituitary adenoma and an intracranial meningioma is a rare event. We report the coexistence of an eosinophilic pituitary adenoma and a endotheliomatous meningioma, in the sellar region, and evaluate their endocrine, neuro-radiological and immunohistochemical pattern. A 47-year-old woman affected by acromegaly was referred to us. Serum GH level was 82 ng/ml and remained unresponsive to both OGTT (75 g per os) and iv. GHRH 1-29 (100 micrograms); IGF-1 was 807 ng/ml. Eight hours after acute sc administration of octreotide (100 micrograms) GH returned to normal levels (2.3 ng/ml). CT scan showed a large intra- and suprasellar mass involving the right cavernous sinus, with a retrosellar extension along the tentorium. A slight and inhomogeneous enhancement, with a periferal rim of bright signal was apparent at MRI. Conversely, the retrosellar component showed a bright homogeneous enhancement. The patient, therefore, underwent neurosurgery. Histological examination revealed the coexistence of 2 types of tissue: areas of endotheliomatous meningioma were interspersed among sheets of acidophilic adenoma tissue. Immunohistochemical analysis was performed in order to determine the relationship between the two masses: a positive staining for GH was shown in the areas of adenoma, as against for GHRH, neither in the adenomatous tissue nor in the slices of meningioma. Although MRI showed a latero-sellar post-surgical residual of meningioma, serum GH value was < 1 ng/ml. In conclusion, the relationship between the GH-secreting adenoma and the meningioma is unclear; however the GH-hypersecretion is not induced by a hypothetic GHRH-activity from the meningioma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282967     DOI: 10.1007/BF03348915

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  [PRIMARY MULTIPLE BRAIN TUMORS].

Authors:  K KITAMURA; H TERAO; S KAMANO; N NAKAMURA; I HAYAKAWA; T ISHIJIMA; K SANO
Journal:  No To Shinkei       Date:  1965-02

2.  Malignant intracranial neoplasms, following radiation therapy for acromegaly.

Authors:  M B GOLDBERG; G E SHELINE; N MALAMUD
Journal:  Radiology       Date:  1963-03       Impact factor: 11.105

3.  [Endocrine polyadenomatosis combined with a tentorial meningioma].

Authors:  H Bankl; V Grunert; M Sunder-Plassmann
Journal:  Wien Klin Wochenschr       Date:  1970-04-03       Impact factor: 1.704

4.  The possible role of radiation in oncogenesis of meningioma.

Authors:  W M Bogdanowicz; E Sachs
Journal:  Surg Neurol       Date:  1974-11

5.  Successful treatment of acromegaly: metabolic and clinical studies in 145 patients.

Authors:  J H Lawrence; C A Tobias; J A Linfoot; J L Born; J T Lyman; C Y Chong; E Manougian; W C Wei
Journal:  J Clin Endocrinol Metab       Date:  1970-08       Impact factor: 5.958

6.  [Suprasellar meningioma and acromegaly].

Authors:  C Biancifiori
Journal:  Lav Ist Anat Istol Patol Univ Studi Perugia       Date:  1970

7.  [Post-radiation meningioma. A late complication of the irradiation of the sella turcica].

Authors:  C Meyrignac; J P N'Guyen; C Blatrix; J D Degos
Journal:  Nouv Presse Med       Date:  1981-10-31

8.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

9.  Pituitary adenoma and meningioma in the same patient. Report of three cases.

Authors:  J Zentner; J Gilsbach
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 10.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

View more
  15 in total

1.  Value of petrosal sinus sampling: coexisting acromegaly, empty sella and meningioma.

Authors:  S Yarman; O Minareci
Journal:  Neuroradiology       Date:  2004-12-04       Impact factor: 2.804

2.  Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.

Authors:  Federica Guaraldi; Valentina Corazzini; Gary L Gallia; Silvia Grottoli; Karen Stals; Nadezhda Dalantaeva; Lawrence A Frohman; Márta Korbonits; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.

Authors:  Lorenzo Curto; Stefano Squadrito; Barbara Almoto; Marcello Longo; Francesca Granata; Francesco Salpietro; Maria L Torre; Fiorella Marini; Francesco Trimarchi; Salvatore Cannavo
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

4.  Coexistence of meningioma and other intracranial benign tumors in non-neurofibromatosis type 2 patients: A case report and review of literature.

Authors:  Tian-Hao Hu; Run Wang; Hai-Yun Wang; Yi-Fu Song; Juan-Han Yu; Zi-Xun Wang; Yu-Zhou Duan; Ting Liu; Sheng Han
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

5.  Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships?

Authors:  E De Menis; G Tulipano; S Villa; D Billeci; C Bonfanti; P Pollara; P Pauletto; A Giustina
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 6.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

7.  Hemangiopericytoma in the setting of acromegaly.

Authors:  W Jeffrey Elias; Isa M Hussaina; James B Chadduck; John A Jane; Edward R Laws; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

8.  Commentary.

Authors:  Lorenzo Curtò
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

9.  Simultaneous Convexity Meningioma and Prolactinoma.

Authors:  Vladimir Figueroa-Angel; Willem Guillermo Calderon-Miranda; Nidia Escobar-Hernandez; Andrei F Joaquim; Luis Rafael Moscote-Salazar; Emericella Renna Roldan-Medellin; Estefania Casasa Velez; Maria Del Rocio Estrada-Hernandez
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

10.  Simultaneous occurrence of cerebellar medulloblastoma and pituitary adenoma: A case report.

Authors:  Vassilis Samaras; Efstathios Samaras; Ioanna Stergiou; Paraskevi Konstantopoulou; Christos Arnaoutoglou; Marianthi Arnaoutoglou; Vassilis Varsos; Calypso Barbatis
Journal:  Cases J       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.